Skip to main content
. 2021 Mar 15;124(9):1516–1523. doi: 10.1038/s41416-021-01261-9

Fig. 3.

Fig. 3

Cumulative excess in cancer-specific mortality rate (per 100,000) after a 6-month disruption compared to undisrupted screening over the years 2020–2030 for the different restart strategies.